The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

SKP SKYEPHARMA PLC ORD 100P



Income Statement  (£ m) 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Continuing Operations
Revenue  55.20 49.90 62.60 73.80 95.90
Operating Profit/(Loss)  9.80 17.10 13.60 21.60 31.50
Net Interest  0.40 11.80 14.10 6.90 1.00
Profit Before Tax  -1.00 -10.40 -1.00 -9.90 30.50
Profit After Tax  -1.60 -10.60 0.80 -11.70 26.30
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  -1.60 -10.60 0.80 -11.70 26.30
Attributable to:
Minority Interests  0.00 0.00 0.00 0.00 0.00
Equity Holders of Parent Company  -1.60 -10.60 0.80 -11.70 26.30
 
Continuing EPS
Earnings per Share - Basic  -6.70p -36.00p 1.80p -13.70p 25.10p
Earnings per Share - Diluted  -6.70p -36.00p 1.70p -13.70p 24.60p
Earnings per Share - Adjusted  1.90p 1.10p 1.80p 17.50p 25.10p
Continuing and Discontinued EPS
Earnings per Share - Basic  -6.70p -14.90p 1.80p -13.70p 25.10p
Earnings per Share - Diluted  -6.70p -14.90p 1.70p -13.70p 24.60p
Earnings per Share - Adjusted  1.90p 22.20p 1.80p 17.50p 25.10p
 
Dividend per Share  0.00p 0.00p 0.00p 0.00p 0.00p

Balance Sheet  (£ m) 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Assets
Non-Current Assets
Property, Plant & Equipment  29.80 31.90 28.50 21.60 20.70
Intangible Assets  5.80 5.10 5.30 6.10 6.50
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 0.00 0.00 0.00 0.40
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  4.20 0.00 0.00 7.20 10.20
  39.80 37.00 33.80 34.90 37.80
Current Assets
Inventories  0.80 5.80 8.80 10.40 9.30
Trade & Other Receivables  10.50 13.30 15.50 14.60 14.90
Cash at Bank & in Hand  15.20 16.40 16.50 32.40 41.10
Current Asset Investments  0.00 0.00 0.00 0.00 0.10
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  26.50 35.50 40.80 57.40 65.40
 
Total Assets  66.30 72.50 74.60 92.30 103.20
 
Liabilities
Current Liabilities
Borrowings  -19.60 -10.10 -9.80 -5.60 -1.60
Other Current Liabilities  -14.80 -24.20 -23.70 -33.30 -36.40
  -34.40 -34.30 -33.50 -38.90 -38.00
 
Net Current Assets  -7.90 1.20 7.30 18.50 27.40
 
Non-Current Liabilities
Borrowings  -94.60 -87.00 -90.90 -11.80 -4.80
Provisions  -5.10 -5.30 -0.10 -5.20 -4.00
Other Non-Current Liabilities  -13.90 -11.90 -14.70 -12.80 -6.50
  -113.60 -104.20 -105.70 -29.80 -15.30
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -148.00 -138.50 -139.20 -68.70 -53.30
 
Net Assets  -81.70 -66.00 -64.60 23.60 49.90
 
Capital & Reserves
Share Capital  98.50 120.70 120.70 179.40 179.40
Share Premium Account  390.20 361.70 361.70 407.20 407.20
Other Reserves  -16.80 -16.40 -16.20 -19.20 -27.00
Retained Earnings  -553.60 -532.00 -530.80 -543.80 -509.70
Shareholders Funds  -81.70 -66.00 -64.60 23.60 49.90
 
Minority Interests/Other Equity  0.00 0.00 0.00 0.00 0.00
Total Equity  -81.70 -66.00 -64.60 23.60 49.90

Ratios - based on IFRS 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14 31-Dec-15
Continuing Operations
PE Ratio - Adjusted  18.82 65.00 62.64 19.14 15.75
PEG - Adjusted  -0.20 -1.54 0.98 0.02 0.36
Earnings per Share Growth - Adjusted  -93.58% -42.11% 63.64% 872.22% 43.43%
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  230.00p 169.15p 135.79p 86.52p 91.51p
Pre-Tax Profit per Share  -4.17p -35.25p -2.17p -11.61p 29.10p
Operating Margin  -1.45% 2.40% 20.77% -4.20% 32.85%
Return on Capital Employed  -1.89% 4.47% 37.43% -6.52% 52.33%
 
Continuing & Discontinued Operations
Dividend Yield  0.00% 0.00% 0.00% 0.00% 0.00%
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  -365.45p -154.14p -151.53p 16.70p 41.41p
Net Gearing  -121.18% -122.27% -130.34% -63.56% -69.54%

Data is provided by Morningstar


Market

Company Information
Updated Monthly
Company address 46-48 Grosvenor Gardens, London, SW1W 0EB, United Kingdom
Company website http://www.skyepharma.c...
Market cap(in millions)* £ 492.62
Listing/Admission to trading 03 May 1996
Trading service SETS
Market MAINMARKET
Listing category Premium Equity Commercial Companies
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
26-May-16
FTSE index FTSE All-Share,FTSE SmallCap,FTSE techMARK Focus,FTSE SmallCap (ex IT),FTSE techMARK mediscience,FTSE techMARK All-Share,FTSE All-Share (ex IT)
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment SSMM
MiFID Status Regulated Market
Exchange market size 500
SEDOL B3BFNB6
ISIN number GB00B3BFNB64



SKYEPHARMA share fundamentals (SKP)